Wednesday’s Midday Stock Update: American Green Inc (ERBB), Nordic American Tanker (NAT), NovaBay Pharma (NBY), Advaxis (ADXS), Xoma Corp (XOMA)

By Carrie Williams

So far Wednesday, May 15, NASDAQ is up 3.85% and the S&P is up 3.19%. Let’s take a look at this morning’s most active stocks and their recent analyst insights; American Green Inc (ERBBResearch Report), Nordic American Tanker (NATResearch Report), NovaBay Pharma (NBYResearch Report), Advaxis (ADXSResearch Report) and Xoma Corp (XOMAResearch Report).

American Green Inc is down -33.33% in midday trading to $0.00. Shares opened today at $0.00. The company has a 52-week low of $0.00 and a 52-week high of $0.00.

Nordic American Tanker is up 15.68% in midday trading to $2.55. Shares opened today at $2.20. The company has a 52-week low of $1.81 and a 52-week high of $0.00. On the Street’s front, the average 12-month analyst price target for the stock is $1.25, marking a -43.18% potential downside from current levels. In a report issued on February 20, Maxim Group analyst James Jang maintained a Sell rating on NAT, with a price target of $1.25, which reflects a potential downside of -43% from last closing price.

NovaBay Pharma is down -12.5% in midday trading to $0.53. Shares opened today at $0.60. The company has a 52-week low of $0.23 and a 52-week high of $0.00. On the Street’s front, the average 12-month analyst price target for the stock is $1.25, marking a 108.33% potential upside from current levels. In a report issued on March 29, H.C. Wainwright analyst Ram Selvaraju reiterated a Hold rating on NBY, with a price target of $1, which implies an upside of 67% from current levels.

See today’s analyst top recommended stocks >>

Advaxis is down -12.2% in midday trading to $3.24. Shares opened today at $3.69. The company has a 52-week low of $2.72 and a 52-week high of $0.00. On the Street’s front, the average 12-month analyst price target for the stock is $5.15, marking a 39.57% potential upside from current levels. In a report issued on April 5, H.C. Wainwright analyst Swayampakula Ramakanth reiterated a Hold rating on ADXS, with a price target of $4.30, which represents a potential upside of 17% from where the stock is currently trading. Over the last 3 months, the insider sentiment on Advaxis has been positive based on 19 corporate insider transactions. This sentiment is slightly higher than the average sector sentiment of insiders.

Xoma Corp is up 11.17% in midday trading to $16.62. Shares opened today at $14.95. The company has a 52-week low of $11.02 and a 52-week high of $0.00. On the Street’s front, the average 12-month analyst price target for the stock is $27.50, marking a 83.95% potential upside from current levels. In a report released yesterday, Wedbush analyst Liana Moussatos reiterated a Buy rating on XOMA, with a price target of $25, which represents a potential upside of 67% from where the stock is currently trading. Separately, on May 6, Cowen’s Phil Nadeau maintained a Hold rating on the stock . In the last 30 days, insiders have sold $1,911 worth of XOMA shares and purchased $408.1K worth of XOMA shares. Over the last 3 months, the insider sentiment on Xoma Corp has been positive based on 13 corporate insider transactions. This sentiment is slightly higher than the average sector sentiment of insiders.

Trending Stocks Based on Insider Activity >>